Toradol
Toradol is a potent nonsteroidal anti-inflammatory drug (NSAID) used for the short-term (up to 5 days) management of moderately severe acute pain that requires analgesia at the opioid level. It works by inhibiting prostaglandin synthesis. It is not indicated for minor or chronic pain due to a high risk of serious adverse effects, including gastrointestinal bleeding, renal failure, and increased bleeding risk.
Dosage by Body Weight
The maximum combined duration of treatment (parenteral and oral) is 5 days. Oral Toradol is only indicated as continuation therapy following initial parenteral (IV or IM) dosing. The typical adult oral dose is 10 mg every 4 to 6 hours as needed, with a maximum of 40 mg per day. Dosage must be reduced for patients over 65 years of age, those under 50 kg (110 lbs), or those with renal impairment.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated
- Frequency
- Do not use
- Tracking Notes
- Toradol is not approved or recommended for use in neonates and infants due to high risks of renal dysfunction and gastrointestinal bleeding.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients of this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Avoid use. In rare, highly controlled inpatient post-operative settings, specialists may use off-label weight-based IV/IM dosing (0.5 mg/kg as a single dose), but routine outpatient use is contraindicated.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Avoid routine outpatient use. Only administered under strict specialist supervision in a hospital setting for short-term post-operative pain.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Oral formulation is not indicated for pediatric patients. For weights under 50 kg, even in adult patients, the maximum daily parenteral/oral dose must be strictly reduced.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated | Do not use | Toradol is not approved or recommended for use in neonates and infants due to high risks of renal dysfunction and gastrointestinal bleeding. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established in pediatric patients of this weight range. |
| 8-10 kg | Not recommended | Do not use | Avoid use. In rare, highly controlled inpatient post-operative settings, specialists may use off-label weight-based IV/IM dosing (0.5 mg/kg as a single dose), but routine outpatient use is contraindicated. |
| 11-15 kg | Not recommended | Do not use | Avoid routine outpatient use. Only administered under strict specialist supervision in a hospital setting for short-term post-operative pain. |
| 16-20 kg | Not recommended | Do not use | Oral formulation is not indicated for pediatric patients. For weights under 50 kg, even in adult patients, the maximum daily parenteral/oral dose must be strictly reduced. |
Formulation
Purpose
Short-term management of moderate to severe acute pain, typically post-operative.
Generic Name
Ketorolac tromethamineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.